Explore the words cloud of the PoC-ID project. It provides you a very rough idea of what is the project "PoC-ID" about.
The following table provides information about the project.
Coordinator |
TECHNISCHE UNIVERSITAT BERLIN
Organization address contact info |
Coordinator Country | Germany [DE] |
Project website | http://www.poc-id.eu/ |
Total cost | 5˙963˙133 € |
EC max contribution | 5˙963˙132 € (100%) |
Programme |
1. H2020-EU.3.1.3. (Treating and managing disease) |
Code Call | H2020-PHC-2014-two-stage |
Funding Scheme | RIA |
Starting year | 2015 |
Duration (year-month-day) | from 2015-05-01 to 2018-11-30 |
Take a look of project's partnership.
# | ||||
---|---|---|---|---|
1 | TECHNISCHE UNIVERSITAT BERLIN | DE (BERLIN) | coordinator | 1˙315˙125.00 |
2 | FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V. | DE (MUNCHEN) | participant | 829˙803.00 |
3 | STICHTING KATHOLIEKE UNIVERSITEIT | NL (NIJMEGEN) | participant | 693˙432.00 |
4 | FRIEDRICH-SCHILLER-UNIVERSITAT JENA | DE (JENA) | participant | 666˙906.00 |
5 | APTARION BIOTECH AG | DE (BERLIN) | participant | 434˙945.00 |
6 | CNM TECHNOLOGIES GMBH | DE (BIELEFELD) | participant | 397˙897.00 |
7 | NOXXON PHARMA AG | DE (BERLIN) | participant | 387˙926.00 |
8 | SIGNALGENERIX LIMITED | CY (LIMASSOL) | participant | 323˙000.00 |
9 | enablingMNT GMBH | DE (BERLIN) | participant | 320˙753.00 |
10 | SERVIZO GALEGO DE SAUDE | ES (Santiago de Compostela) | participant | 214˙606.00 |
11 | MICROPATHOLOGY LIMITED | UK (COVENTRY) | participant | 118˙625.00 |
12 | MERCENE LABS AB | SE (STOCKHOLM) | participant | 115˙000.00 |
13 | VAN HEEREN ARIE HENDRIK | NL (DORDRECHT) | participant | 81˙112.00 |
14 | MEMSOP CONSULTING | RO (VIDRA VRANCEA) | participant | 64˙000.00 |
The aim of the PoC-ID project is to develop new micro- and nanoelectronic-based sensing and integration concepts for advanced miniaturised in vitro diagnostic devices. The project addresses the increasing demand for rapid and ultra-sensitive point-of-care diagnostics to reduce healthcare costs and increase the quality of life with a focus on infectious diseases, one of the world’s leading causes of morbidity and death. Interdisciplinary collaboration using the technology and expertise of the consortium members will be applied to develop and test a breakthrough PoC prototype for the diagnosis of respiratory syncytial virus infections and host responses in the paediatric context. PoC-ID will enable new types of point-of-care diagnostics for virtually any type of complex liquid sample. Applications are disease diagnosis, monitoring of therapeutic responses, clinical research of pathogen-host interaction and personalised medicine. The platform technology can easily be adapted to a variety of diagnostic or biosensing purposes, such as in health/environmental monitoring or food quality testing. PoC-ID will combine the detection of both pathogens and host responses leading to more accurate diagnosis as compared to the current standard which is focused on detection of pathogens only. This novel approach will support prevention and control of pathogen spread and enable faster and more personalised patient treatment. Improved performance in terms of robustness, sensitivity and selectivity will be reached by a combination of innovative nanomembrane technology, molecular engineered capture molecules and two novel sensing concepts. Further advances will be realised in terms of usability and speed of data-analysis arising from the integration of sensors, read-out electronics and microfluidics into one user friendly point-of-care (PoC) platform. Costs of the new disposable sensors will be ultra-low at high volumes, thanks to designing into microelectronics production flows.
Detailed dissemination and communication plan | Documents, reports | 2020-03-20 09:24:43 |
Take a look to the deliverables list in detail: detailed list of PoC-ID deliverables.
year | authors and title | journal | last update |
---|---|---|---|
2018 |
Patrick Reinecke, Marie-Theres Putze, Leopold Georgi, Ruben Kahle, David Kaiser, Daniel Hüger, Pavel Livshits, Jens Weidenmüller, Thomas Weimann, Andrey Turchanin, Tanja Braun, Karl-Friedrich Becker, Martin Schneider-Ramelow, Klaus-Dieter Lang Scalable hybrid microelectronic-microfluidic integration of highly sensitive biosensors published pages: 000672-000679, ISSN: 2380-4505, DOI: 10.4071/2380-4505-2018.1.000672 |
International Symposium on Microelectronics 2018/1 | 2020-03-20 |
2017 |
Pavel Livshits, Andreas Jupe, Stefan Kahnert, Martin Figge, Stefan Mross, Michael Goertz, Holger Vogt, Andreas Goehlich Poster session 10: Medical measuring techniques I published pages: , ISSN: 0013-5585, DOI: 10.1515/bmt-2017-5031 |
Biomedical Engineering / Biomedizinische Technik 62/s1 | 2020-03-20 |
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "POC-ID" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "POC-ID" are provided by the European Opendata Portal: CORDIS opendata.
CeLac and European consortium for a personalized medicine approach to Gastric Cancer
Read MoreEvaluation of Dyadic Psychoeducational Interventions for People with Advanced Cancer and their Informal Caregivers (DIAdIC): An international randomized controlled trial
Read More